Literature DB >> 22026964

Traditional Chinese medicine diagnoses in a sample of women with fibromyalgia.

Scott D Mist1, Cheryl L Wright, Kim Dupree Jones, James W Carson.   

Abstract

BACKGROUND: Traditional Chinese medicine (TCM) offers various treatment modalities guided by TCM diagnoses. In the United States, acupuncture is a commonly employed TCM method for treating a variety of chronic illnesses. Three systematic reviews have been reported recently, reaching differing conclusions about the efficacy of acupuncture for the treatment of fibromyalgia (FM). Among the FM acupuncture studies considered in these reviews, none used TCM diagnosis as an inclusion/exclusion criterion or adjusted treatment based on TCM diagnosis. Overlooking TCM diagnosis may be a reason for such disparate results. PRIMARY STUDY
OBJECTIVE: To obtain TCM diagnoses in a sample of women meeting 1990 American College of Rheumatology criteria for FM who were recruited for a yoga study and to investigate whether there is significant variability. METHODS/
DESIGN: Two TCM practitioners conducted baseline TCM diagnostic examinations on 56 women with FM. A consensus diagnosis was reached based on standardised history, palpation and examination. Canonical discriminate analysis identified two baseline items which predicted TCM diagnosis.
SETTING: School of Nursing, Oregon Health & Science University. PARTICIPANTS: Women, ages 23-75, with FM recruited to a yoga intervention study.
RESULTS: Three primary TCM diagnoses were found in the population: Qi and Blood Deficiency (46.4%, CI 33.0% to 60.36%), Qi and Blood Stagnation (26.8%, CI 15.8% to 40.3%), and Liver Qi Stagnation (19.6%, CI 10.2% to 32.4%).
CONCLUSION: It is likely that previous studies of FM were treating a heterogeneous study population where variable results might be expected. Future acupuncture studies should either control for TCM diagnosis or consider its usefulness as an inclusion/exclusion criterion.

Entities:  

Mesh:

Year:  2011        PMID: 22026964      PMCID: PMC3311157          DOI: 10.1136/acupmed-2011-010052

Source DB:  PubMed          Journal:  Acupunct Med        ISSN: 0964-5284            Impact factor:   2.267


  15 in total

Review 1.  Acupuncture for fibromyalgia--a systematic review of randomized clinical trials.

Authors:  E Mayhew; E Ernst
Journal:  Rheumatology (Oxford)       Date:  2006-12-19       Impact factor: 7.580

2.  The Balance Evaluation Systems Test (BESTest) to differentiate balance deficits.

Authors:  Fay B Horak; Diane M Wrisley; James Frank
Journal:  Phys Ther       Date:  2009-03-27

Review 3.  Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique.

Authors:  S F Dworkin; L LeResche
Journal:  J Craniomandib Disord       Date:  1992

4.  [Alternative and complementary therapies in fibromyalgia syndrome].

Authors:  J Langhorst; W Häuser; D Irnich; N Speeck; E Felde; A Winkelmann; H Lucius; A Michalsen; F Musial
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

5.  Beyond good and bad coping: a multidimensional examination of coping with pain in persons with rheumatoid arthritis.

Authors:  C A Smith; K A Wallston; K A Dwyer; S W Dowdy
Journal:  Ann Behav Med       Date:  1997

6.  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

Authors:  Robert M Bennett; Ronald Friend; Kim D Jones; Rachel Ward; Bobby K Han; Rebecca L Ross
Journal:  Arthritis Res Ther       Date:  2009-08-10       Impact factor: 5.156

7.  Fibromyalgia syndrome.

Authors:  Philip Mease; Lesley M Arnold; Robert Bennett; Annelies Boonen; Dan Buskila; Serena Carville; Amy Chappell; Ernest Choy; Daniel Clauw; Dina Dadabhoy; Michael Gendreau; Don Goldenberg; Geoffrey Littlejohn; Susan Martin; Philip Perera; I Jon Russell; Lee Simon; Michael Spaeth; David Williams; Leslie Crofford
Journal:  J Rheumatol       Date:  2007-06       Impact factor: 4.666

8.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Authors:  F Wolfe; H A Smythe; M B Yunus; R M Bennett; C Bombardier; D L Goldenberg; P Tugwell; S M Campbell; M Abeles; P Clark
Journal:  Arthritis Rheum       Date:  1990-02

Review 9.  Review of the Chinese medical approach to the management of fibromyalgia.

Authors:  Lili Zheng; Ken Faber
Journal:  Curr Pain Headache Rep       Date:  2005-10

10.  An internet survey of 2,596 people with fibromyalgia.

Authors:  Robert M Bennett; Jessie Jones; Dennis C Turk; I Jon Russell; Lynne Matallana
Journal:  BMC Musculoskelet Disord       Date:  2007-03-09       Impact factor: 2.362

View more
  6 in total

1.  Randomized Controlled Trial of Acupuncture for Women with Fibromyalgia: Group Acupuncture with Traditional Chinese Medicine Diagnosis-Based Point Selection.

Authors:  Scott D Mist; Kim Dupree Jones
Journal:  Pain Med       Date:  2018-09-01       Impact factor: 3.750

2.  Experimental Studies of Inter-Rater Agreement in Traditional Chinese Medicine: A Systematic Review.

Authors:  Eric Jacobson; Lisa Conboy; Dolma Tsering; Monica Shields; Patrick McKnight; Peter M Wayne; Rosa Schnyer
Journal:  J Altern Complement Med       Date:  2019-11       Impact factor: 2.579

3.  Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects.

Authors:  Xiao Zhang; Huji Xu; Zhiyi Zhang; Yang Li; Lynne Pauer; Shanmei Liao; Fengchun Zhang
Journal:  J Pain Res       Date:  2021-02-25       Impact factor: 3.133

4.  Interobserver reliability of four diagnostic methods using traditional korean medicine for stroke patients.

Authors:  Ju Ah Lee; Mi Mi Ko; Byoung-Kab Kang; Terje Alraek; Stephen Birch; Myeong Soo Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-09       Impact factor: 2.629

5.  Acupuncture Effects on Blood Parameters in Patients with Fibromyalgia.

Authors:  Habibe İnci; Fatih İnci
Journal:  Med Acupunct       Date:  2021-02-16

6.  A randomized clinical trial of fibromyalgia treatment with acupuncture compared with fluoxetine.

Authors:  M J Hadianfard; M Hosseinzadeh Parizi
Journal:  Iran Red Crescent Med J       Date:  2012-10-30       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.